Raymond James analyst Alexander Sklar downgrades Duck Creek Technologies (NASDAQ:DCT) from Outperform to Market Perform.
Palatin Announces Preliminary Q4 Vyleesi Results: Net Product Revenue Up 122% YoY To $1.7M
Palatin Technologies, Inc. (NYSE:PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced preliminary